Moving Out

by Brad Houle, CFA Executive Vice President

In the month of March, sales of previously owned homes increased to 6.1 percent. Sales of 5.19 million homes is the highest level we’ve seen since 2013. At the height of the housing bubble prior to the great recession in 2008, existing home sales were as high as 7 million a month in the summer of 2005.

Following the 2008 crisis, existing home sales dropped as low as 3.5 million in June of 2010. While we will probably not see a return to 7 million homes sale in a month, the housing market is most certainly recovering. New home sales have followed a similar pattern, peaking prior to the crisis at 1.25 million in the summer of 2005 and now are averaging around 500,000 new homes per month.

Home sales are driven by new household formation as well as job growth. New household formation is defined as  individuals who are between the ages of 25 and 35 moving out of their parents’ basements to live on their own. While many people in the millennial generation prefer to rent, some are becoming first-time home buyers which is driving entry-level housing sales. Payroll growth has been robust with the unemployment rate dropping from 10 percent post-financial crisis to only 5.5 percent. There is a strong correlation with home sales and payroll growth as people become more secure in their employment … home sales follow.

Housing supply is low relative to historical rates with less than 5 months of supply. During the downturn, inventory ballooned to more than 12 months of supply. A lack of supply is driving prices higher in many markets also fueled by low interest rates.

Anecdotally there are tales of home buyer bidding wars in tight markets and other frenzied 2006 housing bubble behavior. According to the S&P/Case Shiller Home Price Index, home prices in the U.S. have only recovered 54 percent of the value lost since 2006. The most important difference between housing activity now and prior to the downturn is that lending requirements are much more stringent than in the past. Gone are the days of stated income loans, also known as liar loans, and no-money-down subprime lending. Lending requirements now require actual income and asset verification as well as a 20 percent  down payment.

Our Takeaway for the Week

o   Despite positive housing news, we do not think this industry is heading into bubble territory

Disclosures

Seasons

by Jason Norris, CFA Executive Vice President of Research

Seasons

The more things change, the more they stay the same. Five months ago, we rebuked the old Wall Street adage of “sell in May and go away” which, through the end of August, was a good call. From May 1^st to Aug 31^st, the S&P 500 was up just over 7 percent. However, just like clockwork, the month of September looks to be producing the same results it historically has. Since 1928, September is the only month out of the twelve that has an average negative return. With only a couple of trading days left, it looks like that trend will not be “bucked” this year. Even though there is still time to pull even, the end of the month is usually the weakest (see below).

Source: Renaissance Macro Research

Send for the Man

While this has been a bad week for stocks, it was also not a good week for healthcare mergers and acquisitions. On Monday afternoon, U.S. Treasury Secretary Jack Lew issued some administrative rules making it harder for U.S. companies to start inversion mergers. This type of merger allows a U.S. company to buy a smaller foreign company and relocate offshore to lower tax jurisdictions (see an earlier post for details). Most of these deals are centered in the healthcare space and while these changes will not stop potential inversions, they are designed to make them more difficult. For example, Medtronic is currently in talks to purchase Covidian (based in Ireland) and would use a meaningful amount of offshore cash to finance the deal. With these new rules, Medtronic would not have access to that cash without paying U.S. taxes. Therefore, they will have to look for other financing means, most likely debt, thus slightly increasing the cost. We still believe the deal will be completed, but it does show that the U.S. Treasury is adamant about changing this part of the U.S. tax code. AbbVie and Shire may also be affected; however, the tax benefits are not as meaningful and the gains from the Shire pipeline are significant enough to proceed.

Lesson Learned

Last week was not a good week for Apple. After announcing a record weekend of sales for the iPhone6 and iPhone6+ with over 10 million handsets sold (and this without shipping any to China), any good financial news was eclipsed by issues with the iPhone6+ bending and a botched iOS update. Investors didn’t have patience for the stock during the last few days. We believe that despite these hiccups, this iPhone launch will net over 60 million units this month, and based on pricing and component costs, should be accretive to gross margins.

What we know

• The trend of September probably won’t be broken and stocks will give back some of their summer gains
• Both buy and sell side analysts have been on the phone with their tax attorneys due to Secretary Jack Lew’s administrative order regarding inversions

Disclosures